DINUTUXIMAB

CHEBI:CHEBI_756755

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
1606283
product_type
HUMAN PRESCRIPTION DRUG
listing_expiration_date
20251231
dosage_form
INJECTION
route
INTRAVENOUS
marketing_category
BLA
active_ingredient_strength
3.5 mg/mL
labeler_name
United Therapeutics Corporation
manufacturer_name
United Therapeutics Corporation
nui
N0000191499
pharm_class_epc
Glycolipid Disialoganglioside-directed Antibody [EPC]
pharm_class
Glycolipid Disialoganglioside-directed Antibody Interactions [MoA]
pharm_class_moa
Glycolipid Disialoganglioside-directed Antibody Interactions [MoA]
marketing_start_date
20150310
package_marketing_start_date
20150310
generic_name
DINUTUXIMAB
active_ingredient_name
DINUTUXIMAB
brand_name
Unituxin
brand_name_base
Unituxin
product_ndc
66302-014
application_number
BLA125516
spl_id
9aa5599e-84a7-4848-bd38-e9a6dff55d0b
package_ndc
66302-014-01
package_description
1 VIAL, SINGLE-DOSE in 1 BOX (66302-014-01) / 5 mL in 1 VIAL, SINGLE-DOSE
unii
7SQY4ZUD30
spl_set_id
d66bdf0d-9d65-45de-ae5b-a58617c27492
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class